FDA-Inspected Site

Trident Health System Irb

2 FDA inspections are on record for Trident Health System Irb in Charleston, United States.

Clean· No action indicated

Charleston, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2018-06-21.

At a glance

Inspections

2

Form 483s

1

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
19 Jun 2018 – 21 Jun 2018Human DrugsClean
25 Jan 2010Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

25 Jan 2010
21 CFR 56.108(a)(1)

Initial and continuing reviews

Cited by Nancy E Fontaine

25 Jan 2010
21 CFR 56.109(f)

Continuing review

Cited by Nancy E Fontaine

25 Jan 2010
21 CFR 56.110(b)

Research not eligible for expedited review

Cited by Nancy E Fontaine

25 Jan 2010
21 CFR 56.115(a)(1)

Copies of all research proposals and related documents

Cited by Nancy E Fontaine

25 Jan 2010
21 CFR 56.115(a)(2)

Minutes of IRB meetings

Cited by Nancy E Fontaine

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 56.108(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 56.109(f)Cited across public-safe Form 483 observations1x
21 CFR 56.110(b)Cited across public-safe Form 483 observations1x
21 CFR 56.115(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 56.115(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 56.115(a)(5)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Trident Health System Irb's 1 Form 483

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat